Diagnostics · 2023 · 10 citations · 24 references
Life SciencesBiophysicsMolecular BiologyAnalytical ChemistryMolecular DiagnosticsNeurodegenerationAlzheimer DiseaseAmyloid FormationFluorescence MicroscopyNeurodegenerative DiseasesProtein AggregationProtein OligomerizationAggregationAlzheimer's Disease DiagnosisAmyloid Beta AggregationAmyloid Beta PeptidesAmyloid FibrilsProtein AggregatesSample Preparation Quality ControlSensitivity
Protein misfolding and aggregation are pathological hallmarks of various neurodegenerative diseases. In Alzheimer's disease (AD), soluble and toxic amyloid-β (Aβ) oligomers are biomarker candidates for diagnostics and drug development. However, accurate quantification of Aβ oligomers in bodily fluids is challenging because extreme sensitivity and specificity are required. We previously introduced surface-based fluorescence intensity distribution analysis (sFIDA) with single-particle sensitivity. In this report, a preparation protocol for a synthetic Aβ oligomer sample was developed. This sample was used for internal quality control (IQC) to improve standardization, quality assurance, and routine application of oligomer-based diagnostic methods. We established an aggregation protocol for Aβ1-42, characterized the oligomers by atomic force microscopy (AFM), and assessed their application in sFIDA. Globular-shaped oligomers with a median size of 2.67 nm were detected by AFM, and sFIDA analysis of the Aβ1-42 oligomers yielded a femtomolar detection limit with high assay selectivity and dilution linearity over 5 log units. Lastly, we implemented a Shewhart chart for monitoring IQC performance over time, which is another important step toward quality assurance of oligomer-based diagnostic methods.
24
Limit of blank, limit of detection and limit of quantitation.
David Armbruster, Terry Pry · PubMed · 2008 · 2.1K citations · Full text
Preparing Synthetic Aβ in Different Aggregation States
W. Blaine Stine, Lisa M. Jungbauer, Chunjiang Yu et al. · Methods in molecular biology · 2010 · 402 citations · Full text
Amyloid‐beta oligomerization in Alzheimer dementia versus high‐pathology controls
Thomas J. Esparza, Hanzhi Zhao, John R. Cirrito et al. · Annals of Neurology · 2012 · 314 citations · Full text